CALCA and Parkinson disease: Furthermore, the KC associated SNP rs12576996 (11q13.1) is an eQTL for a gene (MAP 3K11) that is a potential drug target (CEP-1347), which is currently in clinical trials for Parkinson’s disease, and our findings may support repurposing for KC.